Profusa (PFSA) Income towards Parent Company (2022 - 2026)
Profusa's (PFSA) quarterly Income towards Parent Company came in at -$4.6 million in Q1 2026, down 311.28% year-on-year from $2.2 million in Q1 2025, and up 0.9% quarter-over-quarter from -$4.6 million in Q4 2025.
Profusa (PFSA) Income towards Parent Company (2022 - 2026) Analysis & Trends
Profusa's Income towards Parent Company history runs 5 years deep, the most recent figure standing at -$4.6 million for Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 311.28% year-over-year to -$4.6 million in Q1 2026; TTM through Mar 2026 was -$40.0 million, a 343.98% decrease from a year earlier, with the FY2025 full-year figure at -$70.7 million, down 711.45% from the prior year.
- Income towards Parent Company climbed to -$4.6 million in Q1 2026 per PFSA's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $3.7 million in Q1 2022 and bottomed at -$22.6 million in Q3 2025.
- The 5-year median for Income towards Parent Company is -$367345.0 (2023), against an average of -$2.4 million.
- Across the five-year window, Income towards Parent Company soared 124.82% in 2024 and slumped 24839.79% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at $519485.0 in 2022, then sank by 59.06% to $212692.0 in 2023, then sank by 3666.2% to -$7.6 million in 2024, then jumped by 38.72% to -$4.6 million in 2025, then increased by 0.9% to -$4.6 million in 2026.
- Per Business Quant, the three latest PFSA Income towards Parent Company figures stand at -$4.6 million (Q1 2026), -$4.6 million (Q4 2025), and -$22.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Profusa | 70,771.90 | -304,228.10 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.61 Mn |
| Dec 31, 2025 | -4.65 Mn |
| Sep 30, 2025 | -22.56 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Sep 30, 2024 | 91,177.00 |
| Jun 30, 2024 | -397,487.00 |
| Mar 31, 2024 | -820,277.00 |
| Dec 31, 2023 | 212,692.00 |
| Sep 30, 2023 | -367,345.00 |
| Jun 30, 2023 | 852,389.00 |
| Mar 31, 2023 | 440,895.00 |
| Dec 31, 2022 | 519,485.00 |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 3.71 Mn |